Skip to main content

Shein-Chung Chow

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Ste 1102, 11037 Hock Plaza, Durham, NC 27705

Selected Grants


Targeting the B Cell Response to Treat Antibody-Mediated Rejection

ResearchStatistical Investigator · Awarded by National Institutes of Health · 2021 - 2028

An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease

ResearchBiostatistician · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2027

Red blood cell ATP export and transfusion in sepsis (R01)

ResearchBiostatistician · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2026

Methods to improve efficiency and robustness of clinical trials using information from real-world data with hidden bias

ResearchCo Investigator · Awarded by Food and Drug Administration · 2023 - 2026

Data-driven Approaches to Healthcare Provider Resilience & Burnout during COVID-19

Clinical TrialCo Investigator · Awarded by Department of Defense · 2021 - 2023

Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin

ResearchStatistical Investigator · Awarded by National Institutes of Health · 2016 - 2019

RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse

ResearchStatistician · Awarded by National Institutes of Health · 2013 - 2019

Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders

ResearchPrincipal Investigator · Awarded by University of Texas - Southwestern · 2015 - 2018

Bacteremia Modification 14

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2009 - 2017

Mod 11 for Option 3 - Staphylococcal Bacteremia Study

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2009 - 2017

Modification No 13 Staphylococcal Bacteremia Study

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2009 - 2017

Sample Size Requirements for Analytical Similarity Assessments

ResearchPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2017 - 2017

Modification No. 8 - Staphylococcal Bacteremia Study

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2009 - 2016

Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2014 - 2015

Modification No. 5 - Staphylococcal Bacteremia Study

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2009 - 2015

FAST- MAS Administrative Task Year 2

ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2014

Optimizing duration of antibiotics after valve surgery for infective endocarditis

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2012 - 2014

Clinical Trial Planning in Pompe Disease

ResearchStatistical Investigator · Awarded by National Institutes of Health · 2013 - 2014

Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse

Clinical TrialStatistical Investigator · Awarded by National Institutes of Health · 2009 - 2013

CTSA UL

ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2012

External Relationships


  • Genova, Inc.
  • Statistics Collectives, Inc.
  • Synoes, Inc.
  • Taylor and Francis Group (Informa)
  • The National Academies of Science, Engineering, and Medicine
  • University of Toronto, Canada

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.